iTeos Therapeutics Inc (ITOS) is around the top of the Biotechnology industry according to InvestorsObserver. ITOS received an overall rating of 51, which means that it scores higher than 51 percent of all stocks. iTeos Therapeutics Inc also achieved a score of 86 in the Biotechnology industry, putting it above 86 percent of Biotechnology stocks. Biotechnology is ranked 110 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 51 means the stock is more attractive than 51 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With iTeos Therapeutics Inc Stock Today?
iTeos Therapeutics Inc (ITOS) stock has fallen -7.13% while the S&P 500 has gained 0.42% as of 2:44 PM on Tuesday, Jun 22. ITOS is lower by -$1.74 from the previous closing price of $24.48 on volume of 654,547 shares. Over the past year the S&P 500 has gained 31.93% while ITOS has gained 19.37%. ITOS lost -$1.44 per share the over the last 12 months.
Click Here to get the full Stock Score Report on iTeos Therapeutics Inc (ITOS) Stock.
